ClinLabNavigator Logo
ANA
Available Documents
ABO Blood Group System
ABO Mismatched Allogeneic Transplants
Albumin
Autoimmune Hemolytic Guidelines
Blood Administration
Blood Component Transfusion Guidelines
Blood Donation
CMV Negative Blood Components
Compatibility Testing
Cryoprecipitate
Factor IX Complex
Factor VIIa
Factor VIII Concentrate
Factor VIII Inhibitors
Fresh Frozen Plasma
Granulocyte Transfusion
Hemolysis Following Allogeneic BMT
Informed Consent
Irradiated Blood Components
Leukocyte Reduced Red Cells & Platelets
Massive Transfusion
Neonatal Alloimmune Thrombocytopenia
Nitric Oxide Banked Blood
Other Blood Group Systems
Pediatric & Neonatal Transfusion Practices
Platelet Transfusion
Prenatal & Perinatal Immunohematologic Testing
RBC Transfusion Trigger
Red Blood Cell Transfusion
Rh Blood Group System
RhIG for HDN Prevention
RhIG for Treatment of ITP
Saline Washed Red Blood Cells
Sickle Cell Disease Transfusion
Therapeutic Apheresis
Thrombotic Thrombocytopenic Purpura
Transfusion Reactions
Transfusion Related Acute Lung Injury
Trypanosoma Cruzi Donor Screening
Umbilical Cord Blood Stem Cells
von Willebrands Disease
Warm Autoimmune Hemolytic Anemia
Transfusion

Thrombotic Thrombocytopenic Purpura

Print This Page
E-mail This Page

Once a diagnosis of TTP has been made, plasma exchange should be initiated as soon as possible. If plasma exchange will be delayed for more than a few hours, FFP should be continuously infused until the procedure is started. Daily plasma exchanges using 40 to 60 mL of ABO compatible plasma per kg of body weight should be performed until the platelet count increases above 150,000/uL. Thereafter, plasma exchange should be performed every other day for at least 5 days after the platelet count and lactate dehydrogenase level have normalized. Often times, 15 to 20 treatments may be necessary to achieve remission. Discontinuing plasma exchange too early may result in relapse. Platelet count, hemoglobin and lactate dehydrogenase should be monitored daily throughout the treatment period.



Some investigators have advocated using cryopoor plasma instead of FFP because it contains vWF metalloproteinase, but lacks vWF multimers. However, response rates with cryopoor plasma have not been significantly different from FFP. In some hospitals, Cryo Poor Plasma is substituted for FFP if a patient has not responded after five plasma exchanges with FFP.